ARMISTICE CAPITAL, LLC Insider Trading $EYEG EYEGATE PHARMACEUTICALS INC
Get free email notifications about insider trading for ARMISTICE CAPITAL, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARMISTICE CAPITAL, LLC. ARMISTICE CAPITAL, LLC is 10% Owner in AMAG PHARMACEUTICALS INC. ($AVM) and 10% Owner in Vaxart, Inc. ($AVIR) and Director in Vaxart, Inc. ($AVIR) and 10% Owner in VICAL INC ($VICL) and 10% Owner in Cyclo Therapeutics, Inc. ($CTDH) and 10% Owner in ACHIEVE LIFE SCIENCES, INC. ($ACHV) and 10% Owner in TENAX THERAPEUTICS, INC. ($OXBT) and Director in TENAX THERAPEUTICS, INC. ($OXBT) and 10% Owner in PAIN THERAPEUTICS INC ($PTIE) and 10% Owner in Onconova Therapeutics, Inc. ($ONTX) and 10% Owner in BIO-PATH HOLDINGS INC ($BPTH) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in EYEGATE PHARMACEUTICALS INC ($EYEG) and Director in EYEGATE PHARMACEUTICALS INC ($EYEG) and 10% Owner in ReShape Lifesciences Inc. ($ETRM) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in AYTU BIOSCIENCE, INC ($AYTU) and 10% Owner in Del Frisco's Restaurant Group, Inc. ($DFRG) and 10% Owner in INNOVUS PHARMACEUTICALS, INC. ($INNV) and 10% Owner in Cerecor Inc. ($CERC) and Director in Cerecor Inc. ($CERC) and 10% Owner in Valeritas Holdings Inc. ($VLRX).
ARMISTICE CAPITAL, LLC in EYEGATE PHARMACEUTICALS INC
Trading Symbol: EYEGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARMISTICE CAPITAL, LLC: Director, 10% Owner
Holdings: 3,346,601 shares
Current Value: $5,287,630
Latest Transaction: Jan 08 2021
$EYEG Market Capitalization: $15.24M
$EYEG Previous Close: $1.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ARMISTICE CAPITAL, LLC in EYEGATE PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, ALIM, AVM, AYTU, BPTH, VICL, SAVA, CERC, CTDH, DFRG, EYEG, INNV, ONTX, RSLS, OXBT, TTPH, VLRX, VXRT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | P | 5.23 | 1,531,101 | 8,000,003 | 1,531,101 | |
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 5.23 | 1,531,101 | 8,000,003 | 3,346,601 | 1.8 M to 3.3 M (+84.33 %) |
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | P | 5.23 | 1,531,101 | 8,000,003 | 1,531,101 | |
Jan 08 2021 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 5.23 | 1,531,101 | 8,000,003 | 3,346,601 | 1.8 M to 3.3 M (+84.33 %) |
Feb 10 2020 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 6.04 | 12,000 | 72,480 | 1,815,500 | 1.8 M to 1.8 M (+0.67 %) |
Feb 10 2020 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 6.18 | 11,000 | 67,980 | 1,803,500 | 1.8 M to 1.8 M (+0.61 %) |
Oct 01 2019 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | P | 3.13 | 600,000 | 1,875,000 | 600,000 | |
Oct 01 2019 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 3.17 | 1,000 | 3,170 | 1,792,500 | 1.8 M to 1.8 M (+0.06 %) |
Oct 01 2019 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 3.11 | 4,001 | 12,443 | 1,791,500 | 1.8 M to 1.8 M (+0.22 %) |
Oct 01 2019 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 3.13 | 600,000 | 1,875,000 | 1,787,499 | 1.2 M to 1.8 M (+50.53 %) |
Mar 29 2019 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.31 | 298,189 | 92,439 | 17,812,500 | 17.5 M to 17.8 M (+1.70 %) |
Mar 29 2019 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.31 | 130,811 | 40,551 | 17,514,311 | 17.4 M to 17.5 M (+0.75 %) |
Mar 29 2019 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.35 | 120,647 | 42,226 | 17,383,500 | 17.3 M to 17.4 M (+0.70 %) |
Dec 12 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.41 | 24,153 | 9,978 | 17,262,853 | 17.2 M to 17.3 M (+0.14 %) |
Dec 12 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.42 | 6,800 | 2,865 | 17,238,700 | 17.2 M to 17.2 M (+0.04 %) |
Dec 12 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.41 | 19,400 | 7,869 | 17,231,900 | 17.2 M to 17.2 M (+0.11 %) |
Dec 12 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.39 | 50,000 | 19,605 | 17,212,500 | 17.2 M to 17.2 M (+0.29 %) |
Nov 16 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Option Exercise | P | 0.32 | 625,000 | 200,000 | 625,000 | |
Nov 16 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.47 | 178,136 | 83,724 | 17,162,500 | 17 M to 17.2 M (+1.05 %) |
Nov 16 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.43 | 126,735 | 55,003 | 16,984,364 | 16.9 M to 17 M (+0.75 %) |
Nov 16 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.41 | 50,000 | 20,355 | 16,857,629 | 16.8 M to 16.9 M (+0.30 %) |
Nov 16 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.45 | 5,129 | 2,313 | 16,807,629 | 16.8 M to 16.8 M (+0.03 %) |
May 30 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.57 | 40,700 | 23,317 | 16,802,500 | 16.8 M to 16.8 M (+0.24 %) |
May 30 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.58 | 9,300 | 5,348 | 16,761,800 | 16.8 M to 16.8 M (+0.06 %) |
May 30 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.58 | 8,275 | 4,768 | 16,752,500 | 16.7 M to 16.8 M (+0.05 %) |
May 22 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.56 | 1,725 | 959 | 16,744,225 | 16.7 M to 16.7 M (+0.01 %) |
May 16 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.54 | 10,000 | 5,360 | 16,742,500 | 16.7 M to 16.7 M (+0.06 %) |
May 16 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 0.53 | 5,758 | 3,057 | 16,732,500 | 16.7 M to 16.7 M (+0.03 %) |
May 11 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.54 | 49,142 | 26,438 | 16,726,742 | 16.7 M to 16.7 M (+0.29 %) |
May 11 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.54 | 23,917 | 12,982 | 16,677,600 | 16.7 M to 16.7 M (+0.14 %) |
May 11 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.50 | 103,953 | 51,571 | 16,653,683 | 16.5 M to 16.7 M (+0.63 %) |
May 08 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.49 | 1,300 | 636 | 16,549,730 | 16.5 M to 16.5 M (+0.01 %) |
May 08 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.48 | 35,930 | 17,081 | 16,548,430 | 16.5 M to 16.5 M (+0.22 %) |
May 08 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.49 | 4,149 | 2,018 | 16,512,500 | 16.5 M to 16.5 M (+0.03 %) |
May 08 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.48 | 10,103 | 4,871 | 16,508,351 | 16.5 M to 16.5 M (+0.06 %) |
May 08 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.46 | 66,248 | 30,169 | 16,498,248 | 16.4 M to 16.5 M (+0.40 %) |
May 08 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.45 | 19,500 | 8,697 | 16,432,000 | 16.4 M to 16.4 M (+0.12 %) |
Apr 27 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.54 | 80,000 | 43,016 | 16,412,500 | 16.3 M to 16.4 M (+0.49 %) |
Apr 27 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.54 | 85,522 | 46,250 | 16,332,500 | 16.2 M to 16.3 M (+0.53 %) |
Apr 20 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.53 | 496,304 | 261,701 | 16,246,978 | 15.8 M to 16.2 M (+3.15 %) |
Apr 20 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.48 | 1,256,920 | 599,299 | 15,750,674 | 14.5 M to 15.8 M (+8.67 %) |
Apr 20 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.47 | 781,254 | 370,158 | 14,493,754 | 13.7 M to 14.5 M (+5.70 %) |
Apr 17 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | P | 0.32 | 5,468,750 | 1,750,000 | 5,468,750 | |
Apr 17 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.44 | 1,895,610 | 837,670 | 13,712,500 | 11.8 M to 13.7 M (+16.04 %) |
Apr 17 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.38 | 1,159,167 | 435,731 | 11,816,890 | 10.7 M to 11.8 M (+10.88 %) |
Apr 17 2018 | EYEG | EYEGATE PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 0.33 | 7,425,193 | 2,466,649 | 10,657,723 | 3.2 M to 10.7 M (+229.70 %) |
Page: 1